Literature DB >> 15117732

AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF.

Xing Chen1, Sheri E Kelemen, Michael V Autieri.   

Abstract

OBJECTIVE: Allograft inflammatory factor-1 (AIF-1) is associated with vascular smooth muscle cell (VSMC) activation and vascular injury. The purpose of this study was to characterize the molecular mechanism of AIF-1 growth-enhancing effects in human VSMC. METHODS AND
RESULTS: Primary human VSMCs were stably transduced with AIF-1 retrovirus (RV). Impact on cell growth was evaluated by the increase in cell number, and the effects on gene expression were determined by cDNA microarray analysis. AIF-RV overexpressing cells grew significantly more rapidly than empty-RV control cells in growth medium and serum-reduced medium (P<0.01 and 0.02, respectively). cDNA microarray analysis and Western blotting on serum-starved AIF-1-transduced VSMCs identified increased mRNA expression of several cell cycle proteins and, surprisingly, the cytokine G-CSF. Addition of G-CSF caused a 75% increase in proliferation of VSMCs in the absence of serum growth factors. The proliferative effects of AIF-1 were abrogated by neutralizing antibodies to G-CSF (P<0.05), and AIF-1-transduced VSMCs are chemotactic for human monocytes. Increased expression of G-CSF and colocalization with AIF-1 positive cells were seen in diseased, not normal human coronary arteries.
CONCLUSIONS: This study indicates that AIF-1 enhances VSMC growth by autocrine production of G-CSF, and AIF-1 expression may influence VSMC-inflammatory cell communication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117732     DOI: 10.1161/01.ATV.0000130024.50058.de

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  15 in total

Review 1.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 2.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

3.  Locus-level antagonistic selection shaped the polygenic architecture of human complex diseases.

Authors:  Weichen Song; Kai Yuan; Zhe Liu; Wenxiang Cai; Jue Chen; Shunying Yu; Min Zhao; Guan Ning Lin
Journal:  Hum Genet       Date:  2022-08-09       Impact factor: 5.881

4.  Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.

Authors:  Laisel Martinez; Mikael Perla; Marwan Tabbara; Juan C Duque; Miguel G Rojas; Nieves Santos Falcon; Simone Pereira-Simon; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Kidney360       Date:  2022-01-13

5.  Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice.

Authors:  Laura J Sommerville; Sheri E Kelemen; Michael V Autieri
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

6.  Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.

Authors:  Ying Tian; Laura J Sommerville; Anthony Cuneo; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

7.  Inhibition of allograft inflammatory factor-1 expression reduces development of neointimal hyperplasia and p38 kinase activity.

Authors:  Laura J Sommerville; Chen Xing; Sheri E Kelemen; Satoru Eguchi; Michael V Autieri
Journal:  Cardiovasc Res       Date:  2008-09-08       Impact factor: 10.787

8.  G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.

Authors:  Michael T Kuhlmann; Paulus Kirchhof; Rainer Klocke; Lekbira Hasib; Jörg Stypmann; Larissa Fabritz; Matthias Stelljes; Wen Tian; Melanie Zwiener; Marcus Mueller; Joachim Kienast; Günter Breithardt; Sigrid Nikol
Journal:  J Exp Med       Date:  2006-01-09       Impact factor: 14.307

9.  allograft inflammatory factor 1 functions as a pro-inflammatory cytokine in the oyster, Crassostrea ariakensis.

Authors:  Ting Xu; Jiasong Xie; Baojian Zhu; Xiao Liu; Xinzhong Wu
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

10.  Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women.

Authors:  Silvia Lorente-Cebrián; Pauline Decaunes; Elisabeth Dungner; Anne Bouloumié; Peter Arner; Ingrid Dahlman
Journal:  BMC Endocr Disord       Date:  2013-11-25       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.